Impact of the Transpulmonary Pressure on Right Ventricle Function in Acute Respiratory Distress Syndrome
VD-SDRA
2 other identifiers
interventional
50
1 country
2
Brief Summary
Pulmonary distension induced by mechanical ventilation physiologically alters right ventricle pre and after-load, hence might lead to right ventricle failure. The hypothesis is that in Acute Respiratory Distress Syndrome, the occurence of a right ventricle failure under lung protective ventilation might : i) be correlated to the transpulmonary pressure level, ii) lead to global heart failure, iii) and extremely result in poor outcome and death. The primary objective is to test the impact of transpulmonary pressure on right ventricular function in Acute Respiratory Distress Syndrome in adults and children. Secondary objectives are : i) to compare thresholds of transpulmonary pressure associated with right ventricle failure between children and adults. ii) to assess if there is an association between transpulmonary pressure and morbidity and mortality. \- For pediatric patients, a specific monitoring with electrical impedance tomography (EIT) will allow:
- To assess if the transpulmonary pressure is associated with the level of regional pulmonary overdistention (or collapse) on electrical impedance tomography.(EIT)
- To assess if there is an association between the occurrence of right ventricular failure, and distribution of ventilation on EIT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2019
CompletedFirst Posted
Study publicly available on registry
December 3, 2019
CompletedStudy Start
First participant enrolled
June 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2022
CompletedMarch 11, 2026
March 1, 2026
2 years
November 28, 2019
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Right ventricle failure
Right ventricle failure is defined, by ultrasound, as a composite criteria associating : * end-diastolic right ventricle/left ventricle area ratio \> 0.6 and/or Acute Cor Pulmonale (assocation with a septal dyskinesia), * and/or a tricuspid annular plane systolic excursion \< 1,6 cm (adults), z-score \< -2 (children), * and/or a doppler-derived tricuspid lateral annular systolic velocity (S wave) \< 10 cm/s, * and/or a two-dimensional Fractional Area Change (defined as end-diastolic area - end-systolic area)/end-diastolic area x100) \< 35%, * and/or a peak right ventricle free wall 2D strain \< -30% (adults), z-score \< 2 (children).
Three days
Secondary Outcomes (13)
Airways pressure
Three days
Oesophageal pressure
Three days
Transpulmonary pressure calculation
Three days
Vaso-Active Inotrope Score (VIS)
Three days
Duration of treatment with vasoactive or inotropic drugs
3 months after hospitalization in Intensive Care Unit
- +8 more secondary outcomes
Study Arms (1)
Acute Respiratory Distress Syndrome
OTHERChildren of more than one month of age and adults hospitalized in Intensive Care Unit for Acute Respiratory Distress Syndrome.
Interventions
Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management : * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).
Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).
The right ventricle systolic function will be assessed thanks to a transthoracic cardiac ultrasound in children, and a transthoracic of a transesophageal cardiac ultrasound in adults : Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management : * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).
For pediatric patients: measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management.
Eligibility Criteria
You may qualify if:
- Patients over one month
- Patients with mild to severe ARDS (onset within 48 hours). ARDS definition will follow Berlin guidelines for adults, and Pediatric Acute Lung Injury Consensus Conference (PALICC) guidelines for children
- Signed consent
You may not qualify if:
- Neonates less than 28 days-old
- Pregnancy or breastfeeding
- Any contra-indication to esophageal manometry (less than one month esophagus surgery, bronchopleural or esotracheal fistula, latex allergy)
- No social care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital Ambroise Paré
Boulogne-Billancourt, 92100, France
Hôpital Necker-Enfants Malades
Paris, 75015, France
Related Publications (1)
Vedrenne-Cloquet M, Petit M, Khirani S, Charron C, Khraiche D, Panaioli E, Habib M, Renolleau S, Fauroux B, Vieillard-Baron A. Impact of the transpulmonary pressure on right ventricle impairment incidence during acute respiratory distress syndrome: a pilot study in adults and children. Intensive Care Med Exp. 2024 Sep 27;12(1):84. doi: 10.1186/s40635-024-00671-2.
PMID: 39331249RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meryl Vedrenne-Cloquet, MD
Assistance Publique - Hôpitaux de Paris
- STUDY DIRECTOR
Brigitte Fauroux, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2019
First Posted
December 3, 2019
Study Start
June 11, 2020
Primary Completion
June 11, 2022
Study Completion
June 11, 2022
Last Updated
March 11, 2026
Record last verified: 2026-03